As discussed earlier, CRC TI-Treg cells express immune checkpoint receptors including PD-1, CTLA-4, TIM-3, and the NTPDase CD39 that regulate their immunosuppressive phenotype and support tumor cells in escaping immune surveillance (Figure 1G) (148, 217). The gene discussed is ENTPD1; the disease is neoplasm.